2024 High-cost claims and injectable drug trends analysis
This session will include information from the report such as:
- The top 20 high-cost claim conditions
- A deep dive into newborn related conditions, cardiovascular, cancer and more
- An updated list of the top 20 high-cost injectable drugs
- The continued rise of the most expensive claims
- Our recommendations on supporting better health, care optimization, affordability, risk management and more!